Verve Therapeutics Inc (VERV) — Financial Flexibility Index
Verve Therapeutics Inc (VERV) has a Financial Flexibility Index of -0.19x as of March 2025. Free cash flow of $-26.62 Million (operating CF $-27.84 Million minus capex $1.22 Million) represents 0% of total liabilities ($140.65 Million). Check tangible net worth ratio of Verve Therapeutics Inc to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Verve Therapeutics Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Verve Therapeutics Inc across 6 annual periods. For the full cash flow conversion analysis, see VERV cash flow conversion.
Annual Financial Flexibility Index for Verve Therapeutics Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Verve Therapeutics Inc. Explore Verve Therapeutics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.00x | $-153.96 Million | $-157.69 Million | $153.99 Million | ▼ -9.2% |
| 2023 | -0.92x | $-140.27 Million | $-149.55 Million | $153.19 Million | ▼ -7.7% |
| 2022 | -0.85x | $-109.10 Million | $-122.33 Million | $128.29 Million | ▲ +69.0% |
| 2021 | -2.75x | $-73.52 Million | $-77.88 Million | $26.77 Million | ▼ -1127.5% |
| 2020 | -0.22x | $-31.84 Million | $-35.27 Million | $142.32 Million | ▼ -65.0% |
| 2019 | -0.14x | $-5.58 Million | $-7.44 Million | $41.20 Million | — |